Potentiation by haloperidol of the catalepsy produced by lesions in the parafascicular nucleus of the rat.
D000344:Afferent Pathways / Q000187:drug effects / Q000503:physiopathology; D000818:Animals; D002375:Catalepsy / Q000139:chemically induced / Q000503:physiopathology*; D002421:Caudate Nucleus / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D008297:Male; D011699:Putamen / Q000503:physiopathology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D013378:Substantia Nigra / Q000503:physiopathology; D013787:Thalamic Nuclei / Q000503:physiopathology*
D011954:Receptors, Dopamine; D006220:Haloperidol